The future of PREA involves ongoing efforts to address its limitations and enhance its effectiveness. This includes:
1. Increased Collaboration: Greater collaboration between stakeholders, including industry, academia, and regulatory bodies, to improve study designs and methodologies. 2. Technological Advances: Leveraging advances in technology, such as artificial intelligence and big data, to streamline pediatric research and improve study outcomes. 3. Global Harmonization: Working towards global harmonization of pediatric research requirements to ensure that children worldwide benefit from advances in drug development.
